Trials / Conditions / High-risk Myelodysplastic Syndrome (MDS)
High-risk Myelodysplastic Syndrome (MDS)
5 registered clinical trials studyying High-risk Myelodysplastic Syndrome (MDS) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-r NCT06681363 | Nantes University Hospital | — |
| Not Yet Recruiting | CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS NCT07347418 | University of Colorado, Denver | Phase 1 |
| Terminated | HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Mye NCT03940352 | Novartis Pharmaceuticals | Phase 1 |
| Completed | A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome NCT03787498 | Opna Bio LLC | Phase 1 |
| Terminated | Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodys NCT02198482 | University of Ulm | Phase 2 |